43 matches for your search in the start-up spotlight
rss
Cambridge-based TRIMTECH Therapeutic’s mission is to create novel small molecule degraders of protein aggregates that will combat neurodegenerative and inflammatory diseases including Alzheimer’s disease, a leading cause of death globally. The Company’s proprietary degrader technology is focused ...
Abselion started in 2018, at that time under the name HexagonFab, in a small corner of a laboratory at the University of Cambridge. We set out with the humble goal to make protein research simpler. Scientists should be able to pursue their passion for discovery and innovation, rather than spend ...
Together, we stand at the brink of a journey, charging forth to redefine energy. Systems-level innovation, born from a decade of shared dedication between world-class technicians, scientists, and experts. We believe in a collaborative approach to innovation and a systems-level approach to ...
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base ...
Technology to support sustainable agriculture one microbe at a time. Chemical fertilizers and pesticides have long been the go to solution for farmers looking to enhance their yields. We believe that nature has a viable alternative to replace chemicals, it just needs some help. We have developed ...
Mogrify has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and ...
DIOSynVax customises vaccine antigen design to maximise the protection that vaccines can provide worldwide against existing and future viruses. Grounded firmly in virus structure and evolution, our method is patent protected, combining computational biology with in vitro and in vivo validation, ...
Broken String Biosciences is a genomics company with the goal of developing safer cell and gene therapies by assessing the stability of the genome. The Company is building a technology platform pipeline that will drive the development of cell and gene therapies that are safer by design. Its core ...
Camena Bioscience is a synthetic biology company with novel DNA synthesis technology. Built on over 7 years of innovation and with deep insight to the challenges faced in the pharmaceutical and biotechnology industries, their pioneering platform gSynth™ is rewriting the possibilities of DNA ...
NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 ...
